Please assess the completion status of the following clinical trial:

Trial Title: The PROOF Study: The PICC Related Obstruction Of Flow Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Is indicated for a PICC based on institutional practices~2. Is ≥ 18 years of age~3. Is expected to require use of a PICC for a minimum of 10 days~4. Has normal findings on initial ultrasonography (complete Ultrasound Checklist)~5. Vein used for PICC placement must be a minimum of 5mm in diameter~6. Is able to comprehend and have signed the Informed Consent Form (ICF) to participate in the study (or has the ICF signed by the patient's legal representative)~Exclusion Criteria:~1. Anticipates or has presence of dialysis grafts or other ipsilateral intraluminal devices, including pacemakers (with the exception of peripheral IV catheters)~2. Has current or anticipated hematologic derangements, including:~   * thrombocytopenia~  * history of heparin-induced thrombocytopenia~  * coagulopathy (International Normalized Ratio 2.5 or greater)~  * established diagnosis of hypercoagulable syndrome (e.g., protein C and S deficiency, anti-phospholipid antibody or polycythemia) or requires systemic therapeutic anticoagulation (Note: The following prophylactic treatments are allowed: subcutaneous heparin or enoxaparin sodium injection, and concomitant use of platelet aggregation inhibitors, e.g., Plavix/Ticlid/aspirin)~3. Has central veno-occlusive disease~4. Has history of previous catheter-related thrombosis~5. Has arm identified for catheterization that exhibits any of the following (and the contralateral arm is also unsuitable for PICC placement based on the same criteria):~   * Current (or prior history of) venous thrombosis in all or any portion of the vein where the catheter is expected to reside~  * Conditions that impede venous return from the extremity (such as paralysis or lymphedema after mastectomy)~  * Pre-existing skin surface or subsurface infection at or near the proposed catheter insertion site~  * Anatomical distortions from surgery, injury or trauma (e.g., orthopedic conditions such as compound fractures requiring reconstructive procedures)~  * Anatomical irregularities (structural, vascular, neurological) which may compromise catheter insertion or catheter care procedures in the involved extremity (e.g., reflex sympathetic dystrophy)~6. Is pregnant or lactating~7. Has been previously enrolled in this clinical study, or is participating in another clinical study that is contraindicative to the treatment or outcomes of this investigation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- BioFlo™ PICC (Type: ACTIVE_COMPARATOR): BioFlo™ Peripherally Inserted Central Catheter (PICC)
- Bard® PowerPICC SOLO2® (Type: ACTIVE_COMPARATOR): Bard® Dual-Lumen PowerPICC SOLO2®

Based on this trial design, predict the completion outcome and termination type (if applicable).

Answer: outcome: terminate
termination_type: enrollment issues